ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IKNA Ikena Oncology Inc

1.295
-0.015 (-1.15%)
Last Updated: 13:40:27
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Ikena Oncology Inc IKNA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.015 -1.15% 1.295 13:40:27
Open Price Low Price High Price Close Price Prev Close
1.30 1.28 1.34 1.31
more quote information »

Recent News

Date Time Source Heading
4/10/202408:00GLOBEIkena Oncology to Present at the Stifel 2024 Virtual..
3/12/202408:00GLOBEIkena Oncology Reports Fourth Quarter and Full Year 2023..
3/05/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/27/202408:00GLOBEIkena Oncology to Participate in TD Cowen 44th Annual Health..
2/21/202416:29EDGAR2Form 8-K - Current report
2/21/202416:15GLOBEIkena Oncology Appoints Caroline Germa, M.D. as Chief..
2/02/202417:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202417:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202416:26EDGAR2Form 8-K - Current report
1/18/202416:05GLOBEIkena Oncology Outlines Key Priorities and Provides..
11/09/202307:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202307:09EDGAR2Form 8-K - Current report
11/09/202307:00GLOBEIkena Oncology Shares Initial Positive and Differentiated..
11/07/202308:00GLOBEIkena Oncology to Present at Multiple November 2023 Investor..
10/11/202317:10EDGAR2Form 8-K - Current report
9/25/202316:05EDGAR2Form DEF 14A - Other definitive proxy statements
9/15/202316:05EDGAR2Form PRE 14A - Other preliminary proxy statements
9/12/202316:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
9/11/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
9/05/202308:00GLOBEIkena Oncology to Participate in September 2023 Investor..
8/18/202316:02EDGAR2Form S-3 - Registration statement under Securities Act of..
8/10/202308:00GLOBEIkena Oncology Reports Second Quarter 2023 Financial Results..
8/10/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202308:02EDGAR2Form 8-K - Current report
8/07/202307:00GLOBEIkena Oncology Acquires Pionyr Immunotherapeutics in..
6/30/202317:15EDGAR2Form 8-K - Current report
5/24/202308:00GLOBEIkena Oncology to Participate in Upcoming Investor..
5/15/202307:50GLOBEIkena Oncology Reports First Quarter 2023 Financial Results..
5/15/202307:45GLOBEIkena Oncology Announces $40 Million Underwritten Offering

Your Recent History

Delayed Upgrade Clock